Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo

Hepatocellular carcinoma (HCC) is a highly lethal malignancy mostly because of metastasis, recurrence and acquired resistance to conventional chemotherapy. Arsenic trioxide (ATO) is successfully used to treat hematological malignancies, and has been proven to trigger apoptosis in HCC cells. However,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Song, Jingjing, Zhao, Zhongwei, Fan, Xiaoxi, Chen, Minjiang, Cheng, Xingyao, Zhang, Dengke, Wu, Fazong, Ying, Xihui, Ji, Jiansong
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342569/
https://ncbi.nlm.nih.gov/pubmed/27655700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12041
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires